[Sequential ovariostatic therapy with ethinyl estradiol associated with 6-dehydro-retro-progesterone. Comparative study of 2 different dosages].
D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced; D001835:Body Weight / Q000187:drug effects; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced; D004394:Dydrogesterone / Q000008:administration & dosage*; D004997:Ethinyl Estradiol / Q000008:administration & dosage*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007973:Leukorrhea / Q000139:chemically induced; D007989:Libido / Q000187:drug effects; D009325:Nausea / Q000139:chemically induced; D014592:Uterine Hemorrhage / Q000139:chemically induced
D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D004394:Dydrogesterone
Thérapeutique ovarostatique séquentielle associant l'ethinyl-oestradiol et la 6-déhydro-rétro-progéstrone. Etude comparative de deux différents dosages.